Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors

Identifieur interne : 000491 ( PascalFrancis/Checkpoint ); précédent : 000490; suivant : 000492

Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors

Auteurs : Han-Zhong Zhang [États-Unis] ; HONG ZHANG [États-Unis] ; William Kemnitzer [États-Unis] ; Ben Tseng [États-Unis] ; Jindrich Jr Cinatl [Allemagne] ; Martin Michaelis [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; SUI XIONG CAI [États-Unis]

Source :

RBID : Pascal:06-0304982

Descripteurs français

English descriptors

Abstract

This paper describes the design and synthesis of dipeptidyl N,N-dimethyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. The compounds were tested against SARS-CoV-induced cell death in Vero or CaCo2 cells as a measurement of the inhibiting effects of the compounds on the replication of the virus. Z-Leu-Gln(NMe2)-fmk (6a) was found to be a potent inhibitor with low toxicity in cells, protecting cells with an EC50 value of 2.5 μM and exhibiting a selectivity index of >40.


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:06-0304982

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors</title>
<author>
<name sortKey="Zhang, Han Zhong" sort="Zhang, Han Zhong" uniqKey="Zhang H" first="Han-Zhong" last="Zhang">Han-Zhong Zhang</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hong Zhang" sort="Hong Zhang" uniqKey="Hong Zhang" last="Hong Zhang">HONG ZHANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kemnitzer, William" sort="Kemnitzer, William" uniqKey="Kemnitzer W" first="William" last="Kemnitzer">William Kemnitzer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tseng, Ben" sort="Tseng, Ben" uniqKey="Tseng B" first="Ben" last="Tseng">Ben Tseng</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sui Xiong Cai" sort="Sui Xiong Cai" uniqKey="Sui Xiong Cai" last="Sui Xiong Cai">SUI XIONG CAI</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">06-0304982</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0304982 INIST</idno>
<idno type="RBID">Pascal:06-0304982</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000489</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000501</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000491</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000491</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors</title>
<author>
<name sortKey="Zhang, Han Zhong" sort="Zhang, Han Zhong" uniqKey="Zhang H" first="Han-Zhong" last="Zhang">Han-Zhong Zhang</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hong Zhang" sort="Hong Zhang" uniqKey="Hong Zhang" last="Hong Zhang">HONG ZHANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kemnitzer, William" sort="Kemnitzer, William" uniqKey="Kemnitzer W" first="William" last="Kemnitzer">William Kemnitzer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tseng, Ben" sort="Tseng, Ben" uniqKey="Tseng B" first="Ben" last="Tseng">Ben Tseng</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sui Xiong Cai" sort="Sui Xiong Cai" uniqKey="Sui Xiong Cai" last="Sui Xiong Cai">SUI XIONG CAI</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
<imprint>
<date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral</term>
<term>Cell line</term>
<term>Chemical synthesis</term>
<term>Colon</term>
<term>Dipeptides</term>
<term>Fluorine Organic compounds</term>
<term>Haloketone</term>
<term>Human</term>
<term>In vitro</term>
<term>Ketone</term>
<term>Kidney</term>
<term>Monkey</term>
<term>Peptides</term>
<term>Peptidomimetic compound</term>
<term>Severe acute respiratory syndrome</term>
<term>Severe acute respiratory syndrome virus</term>
<term>Structure activity relation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Synthèse chimique</term>
<term>Dipeptide</term>
<term>Cétone</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus syndrome respiratoire aigu sévère</term>
<term>Antiviral</term>
<term>In vitro</term>
<term>Relation structure activité</term>
<term>Halogénocétone</term>
<term>Composé peptidomimétique</term>
<term>Fluor Composé organique</term>
<term>Peptide</term>
<term>Lignée cellulaire</term>
<term>Singe</term>
<term>Rein</term>
<term>Côlon</term>
<term>Homme</term>
<term>Lignée VERO</term>
<term>Lignée CACO2</term>
<term>Glutamine(N2-benzyloxycarbonylleucyl-1-désoxy-N5,N5-diméthyl-1-fluorométhyl)</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Singe</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">This paper describes the design and synthesis of dipeptidyl N,N-dimethyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. The compounds were tested against SARS-CoV-induced cell death in Vero or CaCo2 cells as a measurement of the inhibiting effects of the compounds on the replication of the virus. Z-Leu-Gln(NMe
<sub>2</sub>
)-fmk (6a) was found to be a potent inhibitor with low toxicity in cells, protecting cells with an EC
<sub>50</sub>
value of 2.5 μM and exhibiting a selectivity index of >40.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0022-2623</s0>
</fA01>
<fA02 i1="01">
<s0>JMCMAR</s0>
</fA02>
<fA03 i2="1">
<s0>J. med. chem. : (Print)</s0>
</fA03>
<fA05>
<s2>49</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>ZHANG (Han-Zhong)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>HONG ZHANG</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>KEMNITZER (William)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>TSENG (Ben)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>CINATL (Jindrich JR)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>MICHAELIS (Martin)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>DOERR (Hans Wilhelm)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>SUI XIONG CAI</s1>
</fA11>
<fA14 i1="01">
<s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>1198-1201</s1>
</fA20>
<fA21>
<s1>2006</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>9165</s2>
<s5>354000135730280370</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>22 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>06-0304982</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of medicinal chemistry : (Print)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>This paper describes the design and synthesis of dipeptidyl N,N-dimethyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. The compounds were tested against SARS-CoV-induced cell death in Vero or CaCo2 cells as a measurement of the inhibiting effects of the compounds on the replication of the virus. Z-Leu-Gln(NMe
<sub>2</sub>
)-fmk (6a) was found to be a potent inhibitor with low toxicity in cells, protecting cells with an EC
<sub>50</sub>
value of 2.5 μM and exhibiting a selectivity index of >40.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B02S05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Synthèse chimique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Chemical synthesis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Síntesis química</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Dipeptide</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Dipeptides</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Dipéptido</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Cétone</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Ketone</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Cetona</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Virus syndrome respiratoire aigu sévère</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Severe acute respiratory syndrome virus</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Severe acute respiratory syndrome virus</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Antiviral</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Antiviral</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Antiviral</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>In vitro</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>In vitro</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>In vitro</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Relation structure activité</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Structure activity relation</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Relación estructura actividad</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Halogénocétone</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Haloketone</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Halocetona</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Composé peptidomimétique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Peptidomimetic compound</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Compuesto peptidomimético</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Fluor Composé organique</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Fluorine Organic compounds</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Fluor Compuesto orgánico</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Peptide</s0>
<s5>32</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Peptides</s0>
<s5>32</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Péptido</s0>
<s5>32</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Lignée cellulaire</s0>
<s5>33</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Cell line</s0>
<s5>33</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Línea celular</s0>
<s5>33</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Singe</s0>
<s5>34</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Monkey</s0>
<s5>34</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA">
<s0>Mono</s0>
<s5>34</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE">
<s0>Rein</s0>
<s5>35</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG">
<s0>Kidney</s0>
<s5>35</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA">
<s0>Riñón</s0>
<s5>35</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE">
<s0>Côlon</s0>
<s5>36</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG">
<s0>Colon</s0>
<s5>36</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA">
<s0>Colón</s0>
<s5>36</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE">
<s0>Homme</s0>
<s5>37</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG">
<s0>Human</s0>
<s5>37</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>37</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE">
<s0>Lignée VERO</s0>
<s4>INC</s4>
<s5>76</s5>
</fC03>
<fC03 i1="19" i2="X" l="FRE">
<s0>Lignée CACO2</s0>
<s4>INC</s4>
<s5>77</s5>
</fC03>
<fC03 i1="20" i2="X" l="FRE">
<s0>Glutamine(N2-benzyloxycarbonylleucyl-1-désoxy-N5,N5-diméthyl-1-fluorométhyl)</s0>
<s2>NK</s2>
<s4>INC</s4>
<s5>78</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="09" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="09" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="09" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="10" i2="X" l="FRE">
<s0>Appareil respiratoire pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG">
<s0>Respiratory disease</s0>
<s5>53</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA">
<s0>Aparato respiratorio patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE">
<s0>Poumon pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG">
<s0>Lung disease</s0>
<s5>54</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA">
<s0>Pulmón patología</s0>
<s5>54</s5>
</fC07>
<fN21>
<s1>198</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>États-Unis</li>
</country>
<region>
<li>District de Darmstadt</li>
<li>Hesse (Land)</li>
</region>
<settlement>
<li>Francfort-sur-le-Main</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Zhang, Han Zhong" sort="Zhang, Han Zhong" uniqKey="Zhang H" first="Han-Zhong" last="Zhang">Han-Zhong Zhang</name>
</noRegion>
<name sortKey="Hong Zhang" sort="Hong Zhang" uniqKey="Hong Zhang" last="Hong Zhang">HONG ZHANG</name>
<name sortKey="Kemnitzer, William" sort="Kemnitzer, William" uniqKey="Kemnitzer W" first="William" last="Kemnitzer">William Kemnitzer</name>
<name sortKey="Sui Xiong Cai" sort="Sui Xiong Cai" uniqKey="Sui Xiong Cai" last="Sui Xiong Cai">SUI XIONG CAI</name>
<name sortKey="Tseng, Ben" sort="Tseng, Ben" uniqKey="Tseng B" first="Ben" last="Tseng">Ben Tseng</name>
</country>
<country name="Allemagne">
<region name="Hesse (Land)">
<name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
</region>
<name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
<name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000491 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000491 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:06-0304982
   |texte=   Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021